Login / Signup

Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure.

Kenji YoshiokaYuya MatsueTetsuo YamaguchiTakeshi KitaiNobuyuki KagiyamaTakahiro OkumuraKeisuke KidaShogo OishiEiichi AkiyamaSatoshi SuzukiMasayoshi YamamotoShunsuke KurodaAkihiko MatsumuraKenzo Hirao
Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2020)
Early initiation of ACEIs/ARBs within 48 h of admission for hospitalized patients with AHF was not associated with adverse events and correlated with improved outcomes at 1 year from admission.
Keyphrases
  • angiotensin converting enzyme
  • angiotensin ii
  • acute heart failure
  • emergency department
  • heart failure
  • type diabetes
  • metabolic syndrome
  • combination therapy
  • atrial fibrillation
  • insulin resistance